NEOGENIX, LLC dba OGENIX

Ogenix manufactures EPIFLO, an FDA-cleared topical oxygen therapy device designed for 24/7 chronic wound treatment. The 3-ounce portable system delivers continuous oxygen therapy to address diabetic foot ulcers, venous stasis ulcers, pressure injuries, surgical wounds, burns, and other non-healing chronic wounds. EPIFLO functions as an adjunct therapy suitable for outpatient and ambulatory wound care settings, enabling clinicians and patients to integrate advanced oxygen-based wound healing into standard clinical management protocols.